Showing results (1671-1680 of 2,031) with videos related to
Sort By:
Pageof 204
Lancet (London, England)|February 15, 1997
Use of antipolymer antibody assay in recipients of silicone breast implantsS A Tenenbaum, J C Rice, L R Espinoza, et al.Cancer|October 26, 2005
Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete responsePooja Rohatgi, Stephen G Swisher, Arlene M Correa, et al.Endocrinology|April 7, 1998
Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulationS R Bornstein, E L Webster, D J Torpy, et al.Mabs|October 25, 2021
Novel chimeric monoclonal antibodies that block fentanyl effects and alter fentanyl biodistribution in miceBhupal Ban, Rodell C Barrientos, Therese Oertel, et al.Journal of Neurovirology|March 19, 2023
Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIVCarrie D Johnston, Erika G Marques de Menezes, Scott Bowler, et al.International Journal of Hepatology|October 15, 2025
Results of a Randomized Controlled Trial Evaluating the Impact of Conversion to LCP Tacrolimus on Neurologic Toxicities in Liver Transplant RecipientsKelsey S Coffman, Gonzalo J Revuelta, Nathan DeTurk, et al.Bioconjugate Chemistry|May 14, 2015
Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriersRashmi Jalah, Oscar B Torres, Alexander V Mayorov, et al.Alcoholism, Clinical and Experimental Research|April 28, 2020
Changes in Hemodynamic Response Function Resulting From Chronic Alcohol ConsumptionJohn E Desmond, Laura C Rice, Dominic T Cheng, et al.Journal of Medicinal Chemistry|February 28, 1997
Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligandsS N Calderon, K C Rice, R B Rothman, et al.International Journal of Gastrointestinal Cancer|May 2, 2006
Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagusPooja R Rohatgi, Stephen G Swisher, Arlene M Correa, et al.Pageof 204